Suppr超能文献

Cyclin E1(CCNE1)作为晚期浆液性卵巢癌患者独立的阳性预后因素 - OVCAD 联盟的研究。

Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients - a study of the OVCAD consortium.

机构信息

Department of Obstetrics and Gynecology, Molecular Oncology Group, Medical University of Vienna, Vienna, Austria.

Department of Obstetrics and Gynecology, Molecular Oncology Group, Medical University of Vienna, Vienna, Austria.

出版信息

Eur J Cancer. 2014 Jan;50(1):99-110. doi: 10.1016/j.ejca.2013.09.011. Epub 2013 Oct 28.

Abstract

Cyclin E, coded by the genes CCNE1 and CCNE2, is the main regulator for transition from G1 to S phase determining cell division. CCNE1 and CCNE2 are known oncogenes in many cancer entities. Especially CCNE1 has frequently been associated with gene amplifications in various malignancies, emphasising its role as a putative oncogene. We determined gene expression and copy number of CCNE1 and CCNE2 by quantitative polymerase chain reaction (PCR) from 172 International Federation of Obstetrics and Gynecology (FIGO) II/III/IV stage serous epithelial ovarian cancer (EOC) tissues and analysed its impact on outcome. Furthermore, whole transcriptome gene expression changes correlating with CCNE1 expression were determined by microarray technology, interpreted by Signalling Pathway Impact Analysis (SPIA), Tool for Inferring Network of Genes (TINGe), and illustrated by hive plots. Protein-protein interaction (PPI) networks were also used for the interpretation. Interestingly, and contradictory to most reports and intuitive expectations, high CCNE1 expression correlated with better overall survival (p=0.005) if corrected for usual clinicopathologic parameters and a molecular subclassification. Using different grading systems or only high graded tumours had no impact on this correlation. Copy number of CCNE1 was increased in 25% of cases which correlated highly significantly with expression but showed no impact on outcome. CCNE2 had no impact on outcomes at all. Whole genome transcriptome analysis revealed 1872 differentially expressed genes correlated to CCNE1 expression, which were significantly enriched with genes from five pathways (e.g. cell cycle and viral carcinogenesis pathway were up-regulated and the Fanconi anaemia pathway was down-regulated). High CCNE1 gene expression is a significant and independent predictor for prolonged overall survival in FIGO III/IV EOC patients. This upside down impact of CCNE1 on survival probably reflects the special characteristic of EOC with tumour dissemination in the near anaerobic peritoneal cavity as the predominant cause of death, compared to other cancer entities where distant metastasis are predominantly lethal.

摘要

细胞周期蛋白 E,由 CCNE1 和 CCNE2 基因编码,是决定细胞分裂从 G1 期到 S 期过渡的主要调节剂。CCNE1 和 CCNE2 是许多癌症实体中的致癌基因。特别是 CCNE1 在各种恶性肿瘤中经常与基因扩增有关,强调了其作为潜在致癌基因的作用。我们通过定量聚合酶链反应(PCR)从 172 例国际妇产科联合会(FIGO)II/III/IV 期浆液性上皮性卵巢癌(EOC)组织中测定了 CCNE1 和 CCNE2 的基因表达和拷贝数,并分析了其对结局的影响。此外,通过微阵列技术确定了与 CCNE1 表达相关的全转录组基因表达变化,并通过信号通路影响分析(SPIA)、基因推断网络工具(TINGe)进行解释,并通过蜂巢图进行说明。还使用蛋白质-蛋白质相互作用(PPI)网络进行解释。有趣的是,与大多数报道和直观的预期相反,如果校正了通常的临床病理参数和分子分类,高 CCNE1 表达与更好的总生存率相关(p=0.005)。使用不同的分级系统或仅高分级肿瘤对这种相关性没有影响。CCNE1 的拷贝数增加了 25%,这与表达高度相关,但对结果没有影响。CCNE2 对结果没有影响。全基因组转录组分析显示,与 CCNE1 表达相关的差异表达基因有 1872 个,这些基因显著富集了来自五个途径的基因(例如,细胞周期和病毒致癌途径上调,范可尼贫血途径下调)。高 CCNE1 基因表达是 FIGO III/IV EOC 患者总生存率延长的显著和独立预测因子。CCNE1 对生存的这种颠倒影响可能反映了 EOC 的特殊特征,即肿瘤在近厌氧的腹膜腔内播散是死亡的主要原因,而与其他癌症实体中主要由远处转移引起的死亡不同。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验